Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Concurrent chemoirradiation; Neoadjuvant chemotherapy; Adjuvant chemotherapy; Dose intensity
مقالات ISI کارسینوم نازوفارنکس (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; N-category staging system; MRI; Neck node levels; IMRT;
Keywords: کارسینوم نازوفارنکس; Matched-pair analysis; Nasopharyngeal carcinoma; Prognostic factor; Radiotherapy; Smoking; Smoking index;
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Radiotherapy; Chemotherapy; Efficacy; Late toxicity;
Keywords: کارسینوم نازوفارنکس; Spinal metastasis; Nasopharyngeal carcinoma; Tokuhashi; Tomita; Bauer; Oswestry
Keywords: کارسینوم نازوفارنکس; Atlas; Organs at risk; Nasopharyngeal carcinoma; Intensity modulated radiotherapy;
Keywords: کارسینوم نازوفارنکس; Chemoradiotherapy; Diffusion-weighted MRI; Nasopharyngeal carcinoma; Treatment assessment;
Keywords: کارسینوم نازوفارنکس; EBV; Nasopharyngeal carcinoma; Etiology; Stromal inflammation; Immune evasion
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Radiation therapy; Oral microbiota; Saliva; Pyrosequencing
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Microdissection; Tumor biomarkers; Proteomic; ENO1; CYPA;
Keywords: کارسینوم نازوفارنکس; Choanal stenosis; Velopharyngeal stenosis; Nasopharyngeal carcinoma; Radiotherapy;
Keywords: کارسینوم نازوفارنکس; ELISA; enzyme-linked immunosorbent assay; SNR; signal-to-noise ratio; EBV; Epstein-Barr virus; NPC; nasopharyngeal carcinoma; BSA; bovine serum albumin; NFDM; nonfat dry milk; PVA; poly(vinyl alcohol); PVP; poly(vinyl pyrrolidone); PBS; phosphate buffered
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Intensity-modulated radiotherapy; Periparotid recurrence; Pattern of failure; Outcomes;
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Radiotherapy; Cranial nerve palsy;
Keywords: کارسینوم نازوفارنکس; Endostatin; Adenovirus vector; Oncolytic virus; Viral-gene therapy; Nasopharyngeal carcinoma;
Keywords: کارسینوم نازوفارنکس; AJCC; American Joint Committee on Cancer; BMI; body mass index; CR; complete response; CSS; cause-specific survival; EBV; Epstein-Barr virus; FFLF; freedom from local failure; FFDF; freedom from distant failure; GORTEC; Oncology and Radiotherapy Group for
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Sex ratio; Sex difference; Aetiology; Oestrogen;
Keywords: کارسینوم نازوفارنکس; Gold nanoparticle; Nasopharyngeal carcinoma; Cytotoxicity; Cancer; Anti-tumor;
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Children and adolescents; Radiotherapy; Survival; Morbidity;
Keywords: کارسینوم نازوفارنکس; HSV; herpes simplex virus; VZV; varicella zoster virus; EBV; Epstein-Barr virus; CMV; cytomegalovirus; HIV; human immunodeficiency virus; CSF; cerebrospinal fluid; BAL; broncho-alveolar lavage; CAEBV; chronic active EBV; NPC; nasopharyngeal carcinoma; PTL
Keywords: کارسینوم نازوفارنکس; Lactate dehydrogenase; Prognosis; Biomarker; Nasopharyngeal carcinoma;
Keywords: کارسینوم نازوفارنکس; Distant metastasis; endostatin; nasopharyngeal carcinoma; prognosis; vascular endothelial growth factor;
Keywords: کارسینوم نازوفارنکس; GNLY, Granulysin; NPC, Nasopharyngeal carcinoma; NPT, Nasopharyngitis; EBV, The Epstein–Barr virus; VCA, Viral capsid antigen; CTL, Cytotoxic T lymphocytes; NK, Natural killerGranulysin; Nasopharyngeal carcinoma; Nasopharyngitis; Epstein–Barr virus; Bioma
Keywords: کارسینوم نازوفارنکس; ISP, inverted Schneiderian papilloma; ESP, exophytic Schneiderian papilloma; ANP, angiectatic nasal polyp; NBF, new bone formationSinonasal tract; Inverted Schneiderian papilloma; Nasopharyngeal carcinoma; Rhinosinusitis; Fibrous dysplasia; Middenbeemster
Long non-coding RNA 319 facilitates nasopharyngeal carcinoma carcinogenesis through regulation of miR-1207-5p/KLF12 axis
Keywords: کارسینوم نازوفارنکس; lncRNAs; long noncoding RNAs; NPC; nasopharyngeal carcinoma; EMT; epithelial-to-mesenchymal transition; ceRNA; competing endogenous RNAs; miR-1207-5p; hsa-miRNA-1207-5p; ANOVA; One-Way Analysis of Variance; GAPDH; glyceraldehydeâ3âphosphate dehydrogen
A single epitope of Epstein-Barr Virus stimulate IgG production in mice
Keywords: کارسینوم نازوفارنکس; EBV; Epitope-based vaccine; gp350/220; Nasopharyngeal carcinoma;
The function and clinical significance of eIF3 in cancer
Keywords: کارسینوم نازوفارنکس; eIFs; eukaryotic translation initiation factors; eIF3; eukaryotic translation initiation factor 3; IRES; internal ribosome entry site; PABP; polyA binding protein; CKIs; cyclin-dependent kinase inhibitors; NER; nucleotide excision repair; GC; gastric carc
Emergency high-flow bypass for the management of ruptured postirradiated internal carotid artery pseudoaneurysms in nasopharyngeal carcinoma patients
Keywords: کارسینوم نازوفارنکس; Pseudoaneurysm; Nasopharyngeal carcinoma; High-flow bypass;
AGR2 diagnostic value in nasopharyngeal carcinoma prognosis
Keywords: کارسینوم نازوفارنکس; AGR2; Anterior Gradient 2; NPC; nasopharyngeal carcinoma; ELISA; enzyme linked immunosorbent assay; MRI; Magnetic Resonance Imaging; PET/CT; position emission tomography/computer tomography; TNM; tumor node metastasis; Biomarker; Diagnostic value; Nasopha
AAA and AXB algorithms for the treatment of nasopharyngeal carcinoma using IMRT and RapidArc techniques
Keywords: کارسینوم نازوفارنکس; AAA; AXB-Dm; AXB-Dw; IMRT; VMAT; RA; Nasopharyngeal carcinoma;
The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Induction chemotherapy; Concurrent chemotherapy; Intensity modulated radiotherapy;
Inhibition of EGF expression and NF-κB activity by treatment with quercetin leads to suppression of angiogenesis in nasopharyngeal carcinoma
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Quercetin; VEGF; Viability; Inhibition;
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; IMRT; Treatment outcomes;
Chemical constituents from Daphne tangutica and their cytotoxicity against nasopharyngeal carcinoma cells
Keywords: کارسینوم نازوفارنکس; Daphne tangutica; Sesquiterpenoids; Nasopharyngeal carcinoma; Cytotoxicity;
ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma
Keywords: کارسینوم نازوفارنکس; ABT-199; Apoptosis; Nasopharyngeal carcinoma; Bcl-2; Mcl-1;
Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Radiomics signature; Predictor; MRI; Induction chemotherapy;
Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients
Keywords: کارسینوم نازوفارنکس; Head and neck cancer; Nasopharyngeal carcinoma; Intensity modulated radiation therapy; Radiation-induced toxicity; Oral mucositis; Predictive model;
Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: Based on hazard-rate and patterns of recurrence
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Conventional two-dimensional radiotherapy; Intensity modulated radiation therapy; Locoregional recurrence; Follow up;
Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysis
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Induction chemotherapy; Locoregionally advanced; Intensity-modulated radiotherapy; Prognosis;
Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinoma
Keywords: کارسینوم نازوفارنکس; Interobserver variations in delineation; Planning target volume; Organs at risk; Nasopharyngeal carcinoma; Intensity-modulated radiation therapy; ABAS; atlas-based automatic segmentation; CV; coefficient of variation; MMR; maximum/minimum ratio; PDC; pres
Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways
Keywords: کارسینوم نازوفارنکس; Calycosin; Nasopharyngeal carcinoma; EWSAT1; TRAF6;
La chimiothérapie néoadjuvante associée à la chimioradiothérapie concomitante dans le traitement du cancer du nasopharynx : expérience du Sud-Tunisien
Keywords: کارسینوم نازوفارنکس; Cancer du nasopharynx; Chimiothérapie première; Radiothérapie; Nasopharyngeal carcinoma; Neoadjuvant chemotherapy; Radiotherapy;
Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; IMRT; Concurrent chemoradiotherapy; Nimotuzumab; Cetuximab; Survival outcome; Adverse events;
Quantitative proteome analysis identifies MAP2K6 as potential regulator of LIFR-induced radioresistance in nasopharyngeal carcinoma cells
Keywords: کارسینوم نازوفارنکس; MAP2K6; Nasopharyngeal carcinoma; LIFR; Radioresistance;
A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Induction chemotherapy; Interaction effect; Prognostic index; Benefit prediction model; Distant metastasis-free survival; aHR; adjusted hazard ratio; AJCC/UICC; American Joint Committee on Cancer/International Union against Cance
LncRNA-LINC00460 facilitates nasopharyngeal carcinoma tumorigenesis through sponging miR-149-5p to up-regulate IL6
Keywords: کارسینوم نازوفارنکس; lncRNAs; long noncoding RNAs; NPC; nasopharyngeal carcinoma; EMT; epithelial-to-mesenchymal transition; ceRNA; competing endogenous RNAs; miR-149-5p; hsa-miRNA-149-5p; ANOVA; one-way analysis of variance; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; I
Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Sequential chemoradiotherapy; Concurrent chemoradiotherapy; Intensity-modulated radiotherapy; Induction chemotherapy; Survival;
TGF-β regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma
Keywords: کارسینوم نازوفارنکس; NPC; nasopharyngeal carcinoma; TGF-β; transforming growth factor beta; EMT; epithelial-mesenchymal transition; lncRNA; long noncoding RNA; AFAP1-AS1; actin filament-associated protein 1 antisense RNA1; MALAT1; metastasis-associated lung adenocarcinoma
LZTS2 inhibits PI3K/AKT activation and radioresistance in nasopharyngeal carcinoma by interacting with p85
Keywords: کارسینوم نازوفارنکس; LZTS2; p85; PI3K; Radioresistance; Nasopharyngeal carcinoma;
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Keywords: کارسینوم نازوفارنکس; Nasopharyngeal carcinoma; Clinical target volume (CTV); Gross target volume (GTV); Guideline; Delineation;